Profit After Tax also registered a robust growth of 51 % YoY at ₹ 38.16 Crores in comparison to ₹ 25.28 Crores reported in Q4 FY21
Best Agrolife Ltd has announced its financial results for Q4 FY22 in its Board of Directors meeting. The fastest-growing agrochemical company in India has reported robust financial results for the fourth quarter ended March 31, 2022 and for the full financial year 2021-22.
Commenting on the results, Managing Director of Best Agrolife Ltd (BAL), Vimal Alawadhi said, “Other than grabbing the registration for the indigenous manufacturing of a number of crucial technicals and pesticides we also bagged two major patents namely Ronfen and Shot Down. We registered remarkable income growth this year, and we closed it with good business momentum. We also started operations in our subsidiary Seedlings India Pvt Ltd plant and our acquired J&K-based unit Agrico which will definitely push the formulation segment and increase the brand business significantly. Overall, the company is in a strong position to utilize the future opportunities and is looking forward to explore the markets outside India in order to expand our global footprints. ”
“The company expects this trend to continue in FY2023. Our R&D team is coming up with a number of innovative and niche chemistry-led products in the coming year thus creating an extremely strong pipeline of business. Our newly launched high-precision products namely Ronfen, Warden, Reveal, Tombo, and Axeman will not only act as real differentiators from conventional crop solutions for farmers but create value for all our stakeholders by increasing the revenue significantly. With our focus on niche products, we are targeting a growth of around 30 per cent and an EBITA of more than 20 per cent in the coming year,”Vimal Alawadhi added further.
Consolidated Key Highlights-Q4 FY 22
The company recorded revenue of ₹ 309.35 Crores for the quarter ended 31 March 2022, a growth of 48.6 per cent YoY as against ₹ 208.13 Crores in Q4 FY21
EBITDA at ₹ 62.1 Crores grew significantly by 68.1% YoY as against ₹ 36.95 Crores in Q4 FY21; EBITDA margin for the quarter was at 20.07 per cent.
PBT was at ₹ 49.33 Crores, a growth of 42.4 % YoY over ₹34.65 Crores reported in the corresponding quarter previous year
PBT also registered a robust growth of 51 % YoY at ₹ 38.16 Crores in comparison to ₹ 25.28 Crores reported in Q4 FY21
Consolidated Key Highlights- FY 22
The company recorded revenue of ₹ 1210.79 Crores in FY22, a growth of 33.7 per cent as against ₹ 905.45 Crores in FY21
EBITDA at ₹ 165.81 Crores grew significantly by 224 per cent as against ₹ 51.18 Crores in FY21; EBITDA margin for FY22 was at 13.69 per cent with respect to 5.65 per cent in FY21.
